Ascletis Pharma
Drug Stores & Pharmacies · North Carolina, United States · 38 Employees
Who is Ascletis Pharma
Ascletis is an innovative R&D driven biotech with two commercial products and listed on Hong Kong Stock Exchange (Ascletis, 1672.HK). Ascletis is committed to developing and commercializing antiviral, steatohepatitis, and tumor-related innovative drugs for unmet medical needs in China and Globally. Led by a management team with deep expertise and a proven track record, Ascletis has developed into a fully integrated platform covering the entire value chain from discovery and development to manufacturing and commercialization. Ascletis' pipeline is focused primarily on three therapeutic areas: 1. HCV: one commercial stage product, one near commercial stage drug and two R&D stage drug candidates. Ganovo® (Danoprevir) is the first direct-acting anti-viral agent for hepatitis C, developed by a domestic firm in China. 2. HBV: one commercial stage product and three R&D stage drug candidates. Pegasys® (Peginterferon alfa-2a) is a leading marketed pegylated interferon for hepatitis B&C partnered with Roche. 3. NASH (Non-Alcoholic SteatoHepatitis): three R&D stage drug candidates against three different targets for combination treatments.Read More
Headquarters:
1002 Northridge Ln, Chapel Hill, North Carolina, 27514, United States
Phone Number:
(919) 928-5707
Revenue:
$6 Million
Ascletis Pharma's Social Media
Popular Searches:
Ascletis Pharma Inc
Ascletis Pharma Inc.
Ascletis Inc
Ascletis
Ascletis Pharmaceuticals Co. Ltd
Top Competitors of Ascletis Pharma
Ascletis Pharma's Org Chart
Phone
Email
PhoneEmail
Ascletis Pharma Company Metrics
Funding
| Funding Date | Round | Amount | Investors | |
|---|---|---|---|---|
Jan 02, 2017 | Series B | $100M | Tasly Pharmaceuticals, Inc | + 2 more  |
Dec 01, 2015 | Unspecified | $20M | Goldman Sachs | |
Sep 01, 2015 | Private Equity | $35M | Tasly Pharmaceuticals, Inc | + 1 more |
See More
$255M
Total Funding Amount
$100M
Most Recent Funding Amount
4
Number of Funding Rounds
Revenue
| Quarter | Revenue |
|---|---|
'21 - Q1 | 7474000 |
'21 - Q2 | 7474000 |
Ascletis Pharma's Tech Stack
Ascletis Pharma News & Media
Ascletis (1672.HK) Included in MSCI China Small Cap Index
HANGZHOU and SHAOXING, China, May 16, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it will be included in the MSCI China Small Cap Index, effective after the market close on May 31, 2022. Morgan Stanley Capital International (MSCI) is a leading...
May 16, 2022
Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab) for Immune Restoration/Functional Cure of HIV-1 Infected Patients
HANGZHOU, China and SHAOXING, China, May 10, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today the Investigational New Drug (IND) application approval of ASC22 (Envafolimab) by U.S. Food and Drug Administration (FDA) for the indication of immune...May 11, 2022Ascletis Announces 3CLpro Inhibitor ASC11 Demonstrated Potential to be Effective Treatment for COVID-19
- In antiviral cellular assays, antiviral potency (EC90) of ASC11 is 31-fold of that of Nirmatrelvir, 120-fold of that of S-217622, 16-fold of that of PBI-0451 and 7-fold of that of EDP-235. - ASC11 is an in-house discovered oral small molecule drug candidate, targeting 3CLpro, with...Apr 19, 2022Subscribe to "Ascletis Pharma" News
Frequently Asked Questions regarding Ascletis Pharma
Where are Ascletis Pharma’s headquarters?
Ascletis Pharma’s headquarters are in 1002 Northridge Ln, Chapel Hill, North Carolina, 27514, United States
What is Ascletis Pharma’s phone number?
Ascletis Pharma’s phone number is (919) 928-5707
What is Ascletis Pharma’s official website?
Ascletis Pharma’s official website is www.ascletis.com
What is Ascletis Pharma’s Revenue?
Ascletis Pharma’s revenue is $6 Million
What is Ascletis Pharma’s SIC code?
Ascletis Pharma’s SIC: 28,283
What is Ascletis Pharma’s NAICS code?
Ascletis Pharma’s NAICS: 32541,325
How many employees are working in Ascletis Pharma?
Ascletis Pharma has 38 employees
What is Ascletis Pharma’s industry?
Ascletis Pharma is in the industry of: Drug Stores & Pharmacies, Retail
Who are Ascletis Pharma’s main competitors?
Ascletis Pharma's main competitors are: NewBridge Pharmaceuticals, Galaxy Trade, Step Pharma, Abivax
What is Ascletis Pharma's tech stack?
The technologies that are used by Ascletis Pharma are: Google Workspace (formerly G Suite), DigiCert, GoDaddy DNS, Bootstrap
Who is Ascletis Pharma's CEO?
Ascletis Pharma's CEO is Jinzi Wu
Rate Jinzi Wu as a Founder, Chairman & Chief Executive Officer
User Ratings 
4.4/5 on G2 Crowd
Test Drive ZoomInfo's Directories
Browse Directories
